Theriva Biologics, Inc.TOVXNYSE
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank50
5Y CAGR-11.3%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-11.3%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 10.84% |
| 2023 | 0.45% |
| 2022 | -48.04% |
| 2021 | -5.93% |
| 2020 | 12.29% |
| 2019 | 19.71% |
| 2018 | 14.48% |
| 2017 | 27.59% |
| 2016 | 28.26% |
| 2015 | -141.87% |